TAIWAN · TWSE / TPEx
FRMSP
台新藥 · 6838 · TWSE (main board) · Biotech and medical
Share price, 2026-10-19NT$25.301 month +8.4% · 1 year -17.0%
Directors and supervisors hold61,931,92141.0% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold61,387,65340.7% of shares issued
Revenue, 2026-09-100.0%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 台耀化學股份有限公司 | Chairman · Director · Major shareholder (10%+) | 61,487,653 | 61,387,653 | 40.66% | — | — |
| 程正禹 | Chairman (corporate representative) | — | 86,274 | 0.06% | — | 197,865 |
| 黃文鴻 | Director (corporate representative) | — | 0 | — | — | — |
| 馬海怡 | Director | 543,268 | 543,268 | 0.36% | — | — |
| 蘇裕惠 | Independent director | — | 0 | — | — | — |
| 羅麗珠 | Independent director | 1,000 | 1,000 | 0.00% | — | — |
| 康照洲 | Independent director | — | 0 | — | — | — |
| 許力克 | President | — | 370,000 | 0.25% | — | 200,000 |
| 魏景成 | Vice president | — | 33,000 | 0.02% | — | 2,000 |
| 陳佑汲 | Assistant vice president | — | 201,238 | 0.13% | — | — |
| 曹乃賢 | Chief financial officer · Chief accountant | — | 260,000 | 0.17% | — | — |